BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.205
+0.035 (2.99%)
Jul 28, 2026, 4:59 PM CET
BioPorto Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -86.09 | -75.45 | -61.17 | -81.53 | -65.26 |
Depreciation & Amortization | 2.51 | 2.38 | 2.68 | 3.97 | 4.33 |
Stock-Based Compensation | -0.64 | -0.88 | 1.38 | 7.56 | -0.97 |
Other Adjustments | 2.22 | -2.38 | 0.05 | 1.64 | 0.31 |
Change in Receivables | -1.23 | -5.85 | 0.65 | 5.02 | -0.77 |
Changes in Inventories | -4.88 | -0.86 | -0.44 | 0.43 | 0.62 |
Changes in Accounts Payable | 2.7 | -6.82 | -3.55 | 6.2 | -0.38 |
Changes in Income Taxes Payable | 5.45 | 4.94 | 5.5 | 5.5 | 5.73 |
Changes in Other Operating Activities | 2.77 | 0.08 | -1.4 | -1.05 | -6.92 |
Operating Cash Flow | -77.07 | -83.58 | -55.46 | -52.49 | -64.58 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.35 | -0.04 | -0.41 | -0.13 |
Purchases of Intangible Assets | - | - | - | -0.06 | -0.26 |
Purchases of Investments | - | - | - | -0.03 | -0.02 |
Proceeds from Sale of Investments | - | 0.76 | -0.24 | - | - |
Other Investing Activities | 1.62 | 2.42 | 0.94 | 1.4 | 0.15 |
Investing Cash Flow | 1.28 | 1.19 | -0.28 | -0.5 | -0.41 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | -0.3 | -0.15 |
Net Long-Term Debt Issued (Repaid) | - | - | - | -0.3 | -0.15 |
Issuance of Common Stock | 76.86 | 81.4 | 46.16 | 100.41 | 4.36 |
Net Common Stock Issued (Repurchased) | 76.86 | 81.4 | 46.16 | 100.41 | 4.36 |
Other Financing Activities | -5.12 | -6.32 | -5.46 | -13.03 | -4.54 |
Financing Cash Flow | 71.94 | 75.47 | 40.79 | 88.7 | 1.1 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.92 | 0.19 | -0.45 | 0.56 | 1.47 |
Net Cash Flow | -3.85 | -6.93 | -14.94 | 35.71 | -63.89 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -77.07 | -83.93 | -55.5 | -52.89 | -64.71 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | -191.29% | -231.58% | -179.26% | -182.58% | -266.79% |
Free Cash Flow Per Share | -0.14 | -0.21 | -0.15 | -0.17 | -0.24 |
Levered Free Cash Flow | -73.58 | -68.88 | -53.58 | -61.59 | -54.01 |
Unlevered Free Cash Flow | -72.13 | -70.46 | -53.55 | -61.27 | -55.12 |